184 related articles for article (PubMed ID: 11160375)
1. Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal alpha-methylacyl-CoA racemase deficiency.
Ferdinandusse S; Overmars H; Denis S; Waterham HR; Wanders RJ; Vreken P
J Lipid Res; 2001 Jan; 42(1):137-41. PubMed ID: 11160375
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency.
Van Veldhoven PP; Meyhi E; Squires RH; Fransen M; Fournier B; Brys V; Bennett MJ; Mannaerts GP
Eur J Clin Invest; 2001 Aug; 31(8):714-22. PubMed ID: 11473573
[TBL] [Abstract][Full Text] [Related]
3. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase.
Ferdinandusse S; Denis S; IJlst L; Dacremont G; Waterham HR; Wanders RJ
J Lipid Res; 2000 Nov; 41(11):1890-6. PubMed ID: 11060359
[TBL] [Abstract][Full Text] [Related]
4. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
[TBL] [Abstract][Full Text] [Related]
5. The role of alpha-methylacyl-CoA racemase in bile acid synthesis.
Cuebas DA; Phillips C; Schmitz W; Conzelmann E; Novikov DK
Biochem J; 2002 May; 363(Pt 3):801-7. PubMed ID: 11964182
[TBL] [Abstract][Full Text] [Related]
6. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
7. Peroxisomal lipid degradation via beta- and alpha-oxidation in mammals.
Mannaerts GP; Van Veldhoven PP; Casteels M
Cell Biochem Biophys; 2000; 32 Spring():73-87. PubMed ID: 11330072
[TBL] [Abstract][Full Text] [Related]
8. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy.
Setchell KD; Heubi JE; Bove KE; O'Connell NC; Brewsaugh T; Steinberg SJ; Moser A; Squires RH
Gastroenterology; 2003 Jan; 124(1):217-32. PubMed ID: 12512044
[TBL] [Abstract][Full Text] [Related]
9. A new defect of peroxisomal function involving pristanic acid: a case report.
McLean BN; Allen J; Ferdinandusse S; Wanders RJ
J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):396-9. PubMed ID: 11861706
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of an alpha-methylacyl-CoA racemase from human liver.
Schmitz W; Albers C; Fingerhut R; Conzelmann E
Eur J Biochem; 1995 Aug; 231(3):815-22. PubMed ID: 7649182
[TBL] [Abstract][Full Text] [Related]
11. Development of a system adapted for the diagnosis and evaluation of peroxisomal disorders by measuring bile acid intermediates.
Kawai H; Takashima S; Ohba A; Toyoshi K; Kubota K; Ohnishi H; Shimozawa N
Brain Dev; 2023 Jan; 45(1):58-69. PubMed ID: 36511274
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy.
Ferdinandusse S; Denis S; Clayton PT; Graham A; Rees JE; Allen JT; McLean BN; Brown AY; Vreken P; Waterham HR; Wanders RJ
Nat Genet; 2000 Feb; 24(2):188-91. PubMed ID: 10655068
[TBL] [Abstract][Full Text] [Related]
13. Clinical consequences of defects in peroxisomal beta-oxidation.
Clayton PT
Biochem Soc Trans; 2001 May; 29(Pt 2):298-305. PubMed ID: 11356171
[TBL] [Abstract][Full Text] [Related]
14. Rapid and quantitative analysis of unconjugated C(27) bile acids in plasma and blood samples by tandem mass spectrometry.
Johnson DW; ten Brink HJ; Schuit RC; Jakobs C
J Lipid Res; 2001 Jan; 42(1):9-16. PubMed ID: 11160360
[TBL] [Abstract][Full Text] [Related]
15. Purification and properties of an alpha-methylacyl-CoA racemase from rat liver.
Schmitz W; Fingerhut R; Conzelmann E
Eur J Biochem; 1994 Jun; 222(2):313-23. PubMed ID: 8020470
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans.
Amery L; Fransen M; De Nys K; Mannaerts GP; Van Veldhoven PP
J Lipid Res; 2000 Nov; 41(11):1752-9. PubMed ID: 11060344
[TBL] [Abstract][Full Text] [Related]
17. A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids.
Savolainen K; Kotti TJ; Schmitz W; Savolainen TI; Sormunen RT; Ilves M; Vainio SJ; Conzelmann E; Hiltunen JK
Hum Mol Genet; 2004 May; 13(9):955-65. PubMed ID: 15016763
[TBL] [Abstract][Full Text] [Related]
18. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
19. The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidney.
Vanhove GF; Van Veldhoven PP; Fransen M; Denis S; Eyssen HJ; Wanders RJ; Mannaerts GP
J Biol Chem; 1993 May; 268(14):10335-44. PubMed ID: 8387517
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
De Biase I; Pasquali M
Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
